This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04736/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04736/identifier/pubchem-compound/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04736/identifier/pubchem-substance/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04736/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04736
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB04736 n8:DB04736
dcterms:title
2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE
adms:identifier
n10:163626 n11:46508748 n12:DB04736 n13:MLD
n3:IUPAC-Name
n4:271B4E72-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E78-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E77-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E74-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E75-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E76-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E70-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E71-363D-11E5-9242-09173F13E4C5 n4:271B4E6E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E6F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E7E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E7F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E79-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E7A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E7C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E7B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E7D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4E84-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E86-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E87-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E83-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E82-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E85-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E73-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E80-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E81-363D-11E5-9242-09173F13E4C5